Saturday 17 October 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024. In the quarter to June 2026, revenue grew 16.4%, EPS grew 12.5% and free cash flow grew 50.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

19.12 0.59 −2.99%

Follow ACAD

Alert me

Market cap: $3.4B
P/E: 8.5×
Fwd P/E: 55.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	13.68	11.51	9.98	11.24
P/S ratio Full definition →		3.44	4.20	3.47	3.81
P/FCF ratio Full definition →		56,296.25	0.00	0.00	0.00
P/Operating CF Full definition →		48.50	(92.28)	111.70	43.08
P/B ratio Full definition →		3.93	3.66	3.04	3.32
Price to Tangible BV Full definition →		4.47	4.02	3.32	3.61
EV/Sales Full definition →		2.63	3.43	2.69	2.97
EV/EBITDA Full definition →		11.14	33.08	33.10	35.22
EV/Operating CF Full definition →		13.85	33.48	23.84	21.12
EV/FCF Full definition →		43,064.04	(39.55)	(35.02)	(65.04)
Quick Ratio Full definition →		2.77	3.49	3.27	3.11
Current Ratio Full definition →		3.02	3.83	3.59	3.39
Net Debt/EBITDA Full definition →		(22.52)	(41.72)	410.14	(23.36)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.91	0.78	0.80	0.77
Operating CF/Net income Full definition →		1.04	(0.18)	9.34	3.20
Capex/Depreciation Full definition →		(53.69)	(1.78)	(2.05)	(1.64)
Research and Development Expense of Revenue Full definition →		31.52%	29.85%	28.68%	26.48%
Selling, General and Administrative Expense of Revenue Full definition →		47.88%	54.80%	63.80%	52.04%
Intangible Assets out of Total Assets Full definition →		0.08	0.07	0.07	0.06
Share Based Compensation of Revenue Full definition →		4.73%	4.66%	5.48%	5.50%
Graham Net Nets Full definition →		0.18	0.16	0.19	0.18
Graham Number Full definition →		13.81	19.51	19.16	19.63
Earnings Yield Full definition →		7.31%	8.69%	10.02%	8.89%
Free Cash Flow Yield Full definition →		0.00%	(2.07%)	(2.22%)	(1.20%)
Revenue per Share Full definition →		1.65	1.69	1.57	1.79
Operating CF per Share Full definition →		0.44	(0.29)	0.20	0.59
Capex per Share Full definition →		(0.59)	(0.02)	(0.03)	(0.03)
Free Cash Flow per Share Full definition →		(0.15)	(0.31)	0.17	0.56
Cash per Share Full definition →		5.02	4.87	4.99	5.57
Shareholders Equity per Share Full definition →		5.43	7.29	7.32	7.61
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		5.43	7.29	7.32	7.61
Free Cash Flow Full definition →		(24.94)	(52.74)	28.77	95.69
Working Capital Full definition →		719.84	785.00	790.49	863.11
Capital Expenditures Full definition →		(99.23)	(4.00)	(5.21)	(5.09)
Net Current Asset Value Full definition →		662.92	725.31	738.85	788.25
EV/EBIT Full definition →		11.44	35.08	36.39	39.20
Capex to Sales Full definition →		0.36	0.01	0.02	0.02
Price to Operating Income Full definition →		14.95	42.90	46.92	50.27
Other line items
Average Receivables Full definition →		124.90	126.46	131.05	143.01
Average Payables Full definition →		20.41	13.55	15.17	32.33
Average Inventory Full definition →		45.07	28.31	27.26	29.25
Average Assets Full definition →		1,153.82	1,375.98	1,368.80	1,484.23
Average Common Equity Full definition →		747.23	980.09	1,006.65	1,064.50

Fold the line items

Columns are period end dates

Stockrow Weekly